Additional induction chemotherapy to concurrent chemotherapy and intensity-modulated radiotherapy with or without nimotuzumab in first-line treatment for locoregionally advanced nasopharyngeal carcinoma: a propensity score matched analysis

Background: The aim of this study is to assess the survival benefits of additional induction chemotherapy before concurrent chemotherapy, intensity-modulated radiotherapy and nimotuzumab in patients with locoregionally advanced nasopharyngeal carcinoma. Methods: Clinical data from 1104 nonmetastatic...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Cancer
Main Authors: Wang, Fangzheng, Sun, Quanquan, Jiang, Chuner, Liu, Tongxin, Rihito, Aizawa, Masoto, Sakamoto, Wang, Yuezhen, Fu, Zhenfu, Chen, Ming
Format: Artigo
Jezik:Inglês
Izdano: Ivyspring International Publisher 2018
Teme:
Research Paper
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5820927/
https://ncbi.nlm.nih.gov/pubmed/29483965
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.20461
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki